Literature DB >> 9088746

Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo.

M Nakamura1, K Ofuji, T Chikama, T Nishida.   

Abstract

PURPOSE: We investigated the combined effects of substance P (SP) and insulin-like growth factor-1 (IGF-1) on corneal epithelial wound closure in vivo.
METHODS: The corneal epithelium of 16 rabbits was debrided by n-heptyl alcohol treatment; SP (1 mg/ml) and/or IGF-1 (1 microgram/ml) in phosphate-buffered saline (PBS) were administered immediately and at 2, 4, 6, 8, 10, 24, 26, 28, 30, 32, and 34 hours after debridement. Controls received PBS alone. The eyes were stained with fluorescein and photographed at baseline and at 6, 12, 18, 24, 30, 36, and 48 hours after debridement. The wound radii of the epithelial defects were recorded from hour 12 to hour 30, and the rate of healing was calculated by linear regression analysis.
RESULTS: The mean (+/-SD) healing rate in the control group was 57.03 +/- 7.88 microns/h. The administration of SP or IGF-1 alone did not affect the healing rates, which were 55.49 +/- 2.49 and 55.57 +/- 7.14 microns/hr, respectively. However, when SP and IGF-1 were combined, the mean healing rate was significantly higher (75.16 +/- 6.68 microns/hr) than that of the control, SP-treated, or IGF-1-treated groups (p < 0.05).
CONCLUSIONS: These results demonstrated that SP and IGF-1 synergistically affect corneal epithelial wound closure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9088746     DOI: 10.1076/ceyr.16.3.275.15409

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  24 in total

1.  Synergistic effect with Phe-Gly-Leu-Met-NH2 of the C-terminal of substance P and insulin-like growth factor-1 on epithelial wound healing of rabbit cornea.

Authors:  M Nakamura; T Chikama; T Nishida
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Substance P affects growth factors in Pseudomonas aeruginosa-infected mouse cornea.

Authors:  Megan E B Foldenauer; Sharon A McClellan; Ronald P Barrett; Yunfan Zhang; Linda D Hazlett
Journal:  Cornea       Date:  2012-10       Impact factor: 2.651

Review 3.  The role of corneal afferent neurons in regulating tears under normal and dry eye conditions.

Authors:  Ian D Meng; Masayuki Kurose
Journal:  Exp Eye Res       Date:  2013-08-28       Impact factor: 3.467

4.  Sensory nerve regeneration after epithelium wounding in normal and diabetic cornea.

Authors:  Fu-Shin Yu; Jia Yin; Patrick Lee; Frank S Hwang; Mark McDermott
Journal:  Expert Rev Ophthalmol       Date:  2015-06-26

Review 5.  The role of fibronectin in corneal wound healing explored by a physician-scientist.

Authors:  Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-07-27       Impact factor: 2.447

6.  Human growth hormone promotes corneal epithelial cell migration in vitro.

Authors:  Juan Ding; Barbara Wirostko; David A Sullivan
Journal:  Cornea       Date:  2015-06       Impact factor: 2.651

Review 7.  Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis.

Authors:  Susmit Suvas
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

Review 8.  Diabetic keratopathy: Insights and challenges.

Authors:  S Priyadarsini; A Whelchel; S Nicholas; R Sharif; K Riaz; D Karamichos
Journal:  Surv Ophthalmol       Date:  2020-02-22       Impact factor: 6.048

9.  Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1.

Authors:  Teruo Nishida; Tai-Ichiro Chikama; Naoyuki Morishige; Ryoji Yanai; Naoyuki Yamada; Jun Saito
Journal:  Jpn J Ophthalmol       Date:  2007-12-21       Impact factor: 2.447

10.  Efficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superficial punctate keratopathy in diabetic patients.

Authors:  Nobuhiko Chikamoto; Tai-Ichiro Chikama; Naoyuki Yamada; Teruo Nishida; Tadashi Ishimitsu; Akira Kamiya
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.